NPTX2
Neuronal pentraxin-2
Also known as: NPTX2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P47972
- Gene
- NPTX2
- Ensembl
- ENSG00000106236
- Chromosome
- 7
- Canonical length
- 431 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Golgi apparatus,Actin filaments,Centrosome
- Secretome location
- Secreted to blood
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes a member of the family of neuronal petraxins, synaptic proteins that are related to C-reactive protein. This protein is involved in excitatory synapse formation. It also plays a role in clustering of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors at established synapses, resulting in non-apoptotic cell death of dopaminergic nerve cells. Up-regulation of this gene in Parkinson disease (PD) tissues suggests that the protein may be involved in the pathology of PD. [provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
431 residues, UniProt reviewed canonical sequence.
>P47972|NPTX2
1 MLALLAASVA LAVAAGAQDS PAPGSRFVCT ALPPEAVHAG CPLPAMPMQG GAQSPEEELR
61 AAVLQLRETV VQQKETLGAQ REAIRELTGK LARCEGLAGG KARGAGATGK DTMGDLPRDP
121 GHVVEQLSRS LQTLKDRLES LEHQLRANVS NAGLPGDFRE VLQQRLGELE RQLLRKVAEL
181 EDEKSLLHNE TSAHRQKTES TLNALLQRVT ELERGNSAFK SPDAFKVSLP LRTNYLYGKI
241 KKTLPELYAF TICLWLRSSA SPGIGTPFSY AVPGQANEIV LIEWGNNPIE LLINDKVAQL
301 PLFVSDGKWH HICVTWTTRD GMWEAFQDGE KLGTGENLAP WHPIKPGGVL ILGQEQDTVG
361 GRFDATQAFV GELSQFNIWD RVLRAQEIVN IANCSTNMPG NIIPWVDNNV DVFGGASKWP
421 VETCEERLLD LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NPTX2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 200 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 200 nTPM
- cerebral cortex: 45 nTPM
- adrenal gland: 39 nTPM
- testis: 33 nTPM
- hypothalamus: 30 nTPM
- blood vessel: 29 nTPM
Single-cell type
- corticotrophs: 336 nCPM
- peritubular myoid cells: 304 nCPM
- myosatellite cells: 224 nCPM
- early primary spermatocytes: 166 nCPM
- schwann cells: 164 nCPM
- pancreatic acinar cells: 119 nCPM
Immune cell
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 280 nTPM
- hypothalamus: 106 nTPM
- hippocampal formation: 81 nTPM
- thalamus: 51 nTPM
- white matter: 35 nTPM
- pons: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NPTX2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NPTX2 as an antibody target. Whether an autoantibody or antibody against NPTX2 could matter depends on whether native NPTX2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NPTX2 is annotated as secreted, so native NPTX2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NPTX2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...